🟢 Senti Biosciences is trading 9.47% up in pre-market with no clear company-specific catalyst identified

Senti Biosciences is trading 9.47% up at $0.33 in pre-market after no clear company-specific catalyst was identified for September 16, 2026.

• Earlier September disclosures included a $2.0 million convertible-note tranche and a $2.5 million equity commitment connected to merger plans.
• Available coverage reports no recent news for the security, leaving the pre-market gain unexplained.